Cargando…
Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
Around 8–12% of patients with advanced colon rectal cancer (CRC) present with BRAF alterations, in particular V600E mutation, which is associated with right-side, poorly differentiated and mucinous type tumors. The presence of BRAF mutation (BRAF-mt) has been identified as a hallmark of poor prognos...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262685/ https://www.ncbi.nlm.nih.gov/pubmed/34249672 http://dx.doi.org/10.3389/fonc.2021.601722 |